Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection
Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection
Endoscopic Injection Sclerotherapy vs N-butyl-2-cyanoacrylate Injection
Endoscopic Injection Sclerotherapy versus N-butyl-2-cyanoacrylate Injection in the Management
 of Actively Bleeding Esophageal Varices
Inclusion Criteria:

 -  cirrhotic patients presented with actively bleeding

 Exclusion Criteria:

 -  other sources of UGIB than esophageal varices, hepatic encephalopathy or
 hepatocellular carcinoma (HCC)